Trial Profile
Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection following the interferon therapy failure compared with de novo therapy with entecavir and telbivudine.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jul 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 26 Jul 2017 New trial record
- 01 Jun 2017 Results published in the Medicine